Cytogenetic aspects of childhood leukemias

Klinische Padiatrie

Volumn 225, Issue SUPPL1, 2013, Pages

  Lampert, F ^a   Harbott, J ^a   Borkhardt, A ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

childhood leukemias; chromosome abnormalities; cytogenetic analysis; hyperdiploidy; translocations

Indexed keywords

ANTILEUKEMIC AGENT; ONCOPROTEIN; PREDNISONE;

ACUTE LEUKEMIA; AGE DISTRIBUTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER THERAPY; CELL CYCLE ARREST; CELL MATURATION; CELL NUCLEUS; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME INSERTION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DISEASE ASSOCIATION; DNA REPAIR; ETV6 RUNX1 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE FUSION; GENE REARRANGEMENT; GENETIC ANALYSIS; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; LEUKOCYTE COUNT; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; MOLECULARLY TARGETED THERAPY; PHILADELPHIA 1 CHROMOSOME; PROTEIN FUNCTION; RECIPROCAL CHROMOSOME TRANSLOCATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TEL-AML1 GENE; TREATMENT DURATION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; DRUG DELIVERY SYSTEMS; GENE REARRANGEMENT; HEMATOPOIESIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA; NEOPLASM, RESIDUAL; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 84878064658     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0033-1337960     Document Type: Article

References (29)

1. Attarbaschi A., Mann G., Panzer-Grumayer R. et al. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. J Clin Oncol: 2008; 26 3046 3050
2. Borkhardt A., Repp R., Haas O. A. et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene: 1997; 14 195 202 (Pubitemid 27068305)
3. Borkhardt A., Bojesen S., Haas O. A. et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci USA: 2000; 97 9168 9173 (Pubitemid 30626692)
4. Boveri Th. Zur Frage der Entstehung maligner Tumoren. Fischer Jena: 1914
5. Corral J., Forster A., Thompson S. et al. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA: 1993; 90 8538 8542 (Pubitemid 23277704)
6. Creutzig U., van den Heuvel-Eibrink M. M., Gibson B. et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood: 2012; 120 3187 3205
7. Gale K. B., Ford A. M., Repp R. et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA: 1997; 94 13950 13954 (Pubitemid 28009690)
8. Greaves M. F. Infection, immune responses and the aetiology of childhood leukaemia. Nature Reviews Cancer: 2006; 6 193 203
9. Harrison C. J. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol: 2009; 144 147 156
10. Lampert F., Harbott J., Ludwig W. D. et al. Acute Leukemia with Chromosome Translocation (4;11): 7 New Patients and Analysis of 71 Cases. Blut: 1987; 54 325 335 (Pubitemid 17086066)
11. Lampert F., Harbott J., Ritterbach J. et al. Karyotypes in Acute Childhood Leukemias May lose Prognostic Significance with More Intensive and Specific Chemotherapy. Cancer Genet Cytogenet: 1991; 54 277 279
12. Lion T., Haas O. A., Harbott J. et al. The Translocation t(1;22)(p13;q13) is a Nonrandom Marker Specifically Associated With Acute Megakaryocytic Leukemia in Young Children. Blood: 1992; 79 3325 3330
13. Möricke A., Zimmermann M., Reiter A. et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia: 2010; 24 265 284
14. Nowell P. C., Hungerford D. A. A minute chromosome in human chronic granulocytic leukemia. Science: 1960; 132 1497
15. Pichler H., Moricke A., Mann G. et al. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. Br J Haematol: 2010; 93 100
16. Pui Ch, Robison L. L., Look A. T. Acute lymphoblastic leukaemia. Lancet: 2008; 371 1030 1043 (Pubitemid 351389536)
17. Repp R., Borkhardt A., Haupt E. et al. Detection of four different 11q23 chromosome abnormalities by multiplex PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia: 1995; 9 210 215
18. Ritterbach J., Hiddemann W., Beck J. D. et al. Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH). Leukemia: 1998; 12 427 433 (Pubitemid 28138229)
19. Robinson H. M., Broadfield Z. J., Cheung K. L. et al. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia: 2003; 17 2249 2250 (Pubitemid 37428400)
20. Romana S. P., Le Coniat M., Berger R. t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer: 1994; 9 186 191 (Pubitemid 24074736)
21. Rowley J. D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature: 1973; 243 290 293
22. Russell L. J., Capasso L., Vater I. et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood: 2009; 114 2688 2698
23. Secker-Walker L. M., Lawler S. D., Haristy R. Prognostic implications of chromsomal findings in acute lymphoblastic leukaemia at diagnosis. Br med J: 1978; 2 1529 1530 (Pubitemid 9058551)
24. Schlieben S., Borkhardt A., Reinisch I. et al. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM 90 and CoALL-05-92. Leukemia: 1996; 10 957 963 (Pubitemid 26235927)
25. Schoumans J., Johansson B., Corcoran M. et al. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol: 2006; 135 492 499 (Pubitemid 44583413)
26. Soulier J., Trakhtenbrod L., Naijfeldet V. et al. Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup. Leukemia: 2000; 317 1679 1682 (Pubitemid 36986978)
27. Tosi S., Harbott J., Teigler-Schlegel A. et al. t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia. Genes Chromosomes Cancer: 2000; 29 325 332
28. Von Bergh A. R., Gargallo P., De Prijk B. et al. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer: 2006; 45 731 739
29. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98